Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Digital Genome Market?

The size of the digital genome market has seen a swift expansion in recent times. A rise from $39.25 billion in 2024 to $46.94 billion in 2025 is projected, exhibiting a compound annual growth rate (CAGR) of 19.6%. Factors such as increased finances for genomics, decrease in DNA sequencing costs and its rapid process, the introduction of fresh competitors and startups in emerging markets, a surge in drug discoveries, and the expansion of the biotech sector can be attributed to the substantial growth during the historical period.

What Growth Rate Is Forecasted for the Digital Genome Market by 2029?

In the coming years, the digital genome market size is anticipated to experience swift expansion. It is forecasted to surge to $97.13 billion by 2029, growing at a compound annual growth rate (CAGR) of 19.9%. The expected growth during the projection period is largely attributed to the growing occurrence of genetic disorders, increased research and development in digital genome, the increased use of personalized medicine, advancements in biotechnology, and the mounting prevalence of chronic diseases. Key trends for the forecast period encompass the escalating adoption of next-generation sequencing technologies, advanced technological developments, the widespread use of microorganisms in the diagnostics sector, the increasing need for personalized medication, and the accelerated adoption of digital genomic technology in hospitals and clinics.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14086&type=smp

Which Key Companies Are Shaping the Future of the Digital Genome Market?

Major companies operating in the digital genome market are Roche Holding AG, Thermo Fisher Scientific Inc., GE HealthCare Technologies Inc., Quest Diagnostics, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., bioMerieux SA, PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., BGI Genomics, Myriad Genetics Inc., Foundation Medicine Inc., ArcherDx Inc., Invitae Corporation, Oxford Nanopore Technologies Ltd., Luminex Corporation, GenMark Diagnostics Inc., NanoString Technologies Inc., Pacific Biosciences of California Inc., Genewiz, Inscripta Inc., Genomic Health Inc., Becton Dickinson and Company, GenomeMe, Regeneron Pharmaceuticals Inc.

Which Factors Are Driving Demand in the Digital Genome Industry?

The digital genome market is expected to expand due to the rising occurrence of genetic abnormalities. These disorders, brought about by irregularities or mutations in a person’s DNA – the genetic blueprint for body growth and functionality – are typically passed down through generations. Digital genome technologies make it possible to pinpoint these genetic alterations and disparities linked to genetic disorders. Such details facilitate the precise and early detection of these disorders, permitting immediate intervention and management. For example, statistics from the National Library of Medicine revealed in August 2023 that about 1 in 500 African Americans in the United States suffer from the genetic disorder known as sickle cell anemia. Furthermore, approximately 1 in 12 African Americans possesses the autosomal recessive mutation causing the disease, and an estimated 300,000 infants contract sickle cell anemia each year. Owing to these alarming statistics regarding genetic abnormalities, the digital genome market is set to grow significantly.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=14086&type=smp

How Is the Digital Genome Market Segmented by Several Divisions?

The digital genome market covered in this report is segmented –

1) By Type: Sequencing And Analyzer Instruments, Data Analysis And Management Tools

2) By Application: Diagnostics, Agriculture And Animal Research, Personalized Medicine, Drug Discovery, Treatment Analysis

3) By End User: Research Centers And Government Institutes, Academic Institutions, Pharmaceutical And Biotechnology Industries, Hospitals, Diagnostic Centers

Subsegments:

1) By Sequencing And Analyzer Instruments: Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Single-Cell Sequencing Instruments, Third-Generation Sequencing Instruments

2) By Data Analysis And Management Tools: Bioinformatics Software, Data Management Platforms, Cloud-Based Analysis Solutions, Workflow Management Tools

What are the Emerging Market Trends Driving the Growth of the Digital Genome Industry?

Key enterprises in the digital genome industry are advancing with novel products like the NovaSeq X Series to enhance disease comprehension and ultimately revolutionize patient healthcare. The NovaSeq X Series encompasses the NovaSeq X and NovaSeq X Plus devices, with the latter capable of performing over 128 genome sequencing per run and over 20,000 whole genomes annually. For example, Illumina, Inc., a biotech corporation based in the US, unveiled the NovaSeq X Series in September 2022, marking a significant leap in whole-genome sequencing technology. This system integrates cost-efficiency, simplified informatics, operational ease, sustainability improvements, and world-class support. It further facilitates comprehensive and more profound sequencing, thereby enabling users to upscale applications including more samples and efficient data analysis. The NovaSeq X Series is engineered to be the most powerful and cost-effective sequencing system, featuring enhanced reagent stability and swift data transfers due to optimized genomics data compression. The system is intentionally built for better sustainability, minimizing the data footprint that cuts down on storage and energy costs.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/digital-genome-global-market-report

Which Regions Are Driving Growth in the Digital Genome Market?

North America was the largest region in the digital genome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital genome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14086

This Report Delivers Insight On:

1. How big is the digital genome market, and how is it changing globally?

2. Who are the major companies in the digital genome market, and how are they performing?

3. What are the key opportunities and risks in the digital genome market right now?

4. Which products or customer segments are growing the most in the digital genome market?

5. What factors are helping or slowing down the growth of the digital genome market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model